Physician profile
Sarah Anne Coughlin
NPI 1568182202
$640.94
in general payments reported to CMS, 2019-2025
8 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Women'S Health Care, Ambulatory provider received nationally (typical 2025 total: $102).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $122 · 2024: $327 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $242.71 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $107.95 | 2023-2025 | Slynd |
| Hologic Sales and Service, LLC | $94.42 | 2024-2025 | Novasure, Aptima, Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $54.92 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $41.79 | 2023-2024 | Gardasil 9, Gardasil |
| Coopersurgical, INC. | $39.57 | 2024-2025 | Paragard T 380a |
| Abbvie INC. | $39.38 | 2023 | |
| Baxter Healthcare | $20.20 | 2024 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Coughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.